Ignite Creation Date:
2025-12-24 @ 10:41 PM
Ignite Modification Date:
2026-05-20 @ 10:14 AM
Study NCT ID:
NCT02499835
Status:
COMPLETED
Last Update Posted:
2023-08-01
First Post:
2015-07-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer
Sponsor:
University of Wisconsin, Madison
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hormone-Resistant Prostate Cancer | View |
| None | Metastatic Malignant Neoplasm in the Bone | View |
| None | Metastatic Malignant Neoplasm in the Soft Tissues | View |
| None | Metastatic Prostate Carcinoma | View |
| None | Prostate Adenocarcinoma | View |
| None | Recurrent Prostate Carcinoma | View |
| None | Stage IV Prostate Cancer | View |
Keywords: